Skip to main content

Advertisement

SpringerLink
Log in

Colorectal Cancer Screening and Prevention in Women

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Colorectal cancer (CRC) is one of the leading cancers and cause of cancer deaths in American women and men. Females and males share a similar lifetime cumulative risk of CRC however, substantial differences in risk factors, tumor biology, and effectiveness of cancer prevention services have been observed between them. This review distills the evidence documenting the unique variation observed between the genders relating to CRC risk factors, screening and prevention. Consistent evidence throughout the world demonstrates that women reach equivalent levels of adenomas and CRC as men but it occurs nearly a decade later in life than in their male counterparts. Women have a higher proportion of tumors which are hypermethylated, have microsatellite instability and located in the proximal colon suggesting the serrated pathway may be of greater consequence in them than in men. Other CRC risk factors such as smoking, diet and obesity have been shown to have disparate effects on women which may related to interactions between estrogen exposure, body fat distribution, and the biologic underpinnings of their tumors. There is data showing the uptake, choice, and efficacy of different CRC screening methods in women is dissimilar to that in men. The mortality benefit from FOBT, sigmoidoscopy, and protection from interval CRC by colonoscopy appears to be lower in women than men. A greater understanding of these gender idiosyncrasies will facilitate an personalized approach to CRC prevention and should ultimately lead to a reduced burden of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. U.S. Department of Health and Human Services. Health Resources and Services Administration. Women’s Health USA 2012. 2013. http://mchb.hrsa.gov/whusa13/. Accessed 24 Nov 2014.

  2. Manser CN, Bauerfeind P. Impact of socioeconomic status on incidence, mortality, and survival of colorectal cancer patients: a systematic review. Gastrointest Endosc. 2014;80:42.e9–60.e9.

    Article  Google Scholar 

  3. American Cancer Society. Cancer Facts and Figures 2014–2016. http://www.cancer.org/acs/groups/content/documents/document/acspc-042280.pdf. Accessed 17 July 2014.

  4. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

    Article  PubMed  Google Scholar 

  5. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355:1863–1872.

    Article  CAS  PubMed  Google Scholar 

  6. Brenner H, Hoffmeister M, Arndt V, Haug U. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer. 2007;96:828–831.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Nguyen SP, Bent S, Chen YH, Terdiman JP. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol.. 2009;7:676.e1-3–681.e1-3.

    Google Scholar 

  8. McCashland TM, Brand R, Lyden E, de Garmo P. CORI Research Project. Gender differences in colorectal polyps and tumors. Am J Gastroenterol. 2001;96:882–886.

    Article  CAS  PubMed  Google Scholar 

  9. Brenner H, Altenhofen L, Hoffmeister M. Sex, age, and birth cohort effects in colorectal neoplasms: a cohort analysis. Ann Intern Med. 2010;152:697–703.

    Article  PubMed  Google Scholar 

  10. Ferlitsch M, Reinhart K, Pramhas S, et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA. 2011;306:1352–1358.

    Article  CAS  PubMed  Google Scholar 

  11. Lieberman DA, Holub JL, Moravec MD, Eisen GM, Peters D, Morris CD. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA. 2008;300:1417–1422.

    Article  CAS  PubMed  Google Scholar 

  12. Surveillance, epidemiology and end results (SEER) program SEER*Stat database: NAACCR incidence—CiNA analytic file, 1995–2010, for expanded races, custom file with county, ACS facts and figures projection project, North American Association of central cancer registries. 2013.

  13. Menigatti M, Truninger K, Gebbers JO, Marbet U, Marra G, Schar P. Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Oncogene. 2009;28:899–909.

    Article  CAS  PubMed  Google Scholar 

  14. van Rijnsoever M, Grieu F, Elsaleh H, Joseph D, Iacopetta B. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut.. 2002;51:797–802.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Poynter JN, Siegmund KD, Weisenberger DJ, et al. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev. 2008;17:3208–3215.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Wiencke JK, Zheng S, Lafuente A, et al. Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:501–506.

    CAS  PubMed  Google Scholar 

  17. Chen D, Huang JF, Liu K, et al. BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis. PLoS One. 2014;9:e90607.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  18. Anderson JC, Rangasamy P, Rustagi T, et al. Risk factors for sessile serrated adenomas. J Clin Gastroenterol. 2011;45:694–699.

    Article  PubMed  Google Scholar 

  19. Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006;131:1400–1407.

    Article  CAS  PubMed  Google Scholar 

  20. Vu HT, Lopez R, Bennett A, Burke CA. Individuals with sessile serrated polyps express an aggressive colorectal phenotype. Dis Colon Rectum. 2011;54:1216–1223.

    Article  PubMed  Google Scholar 

  21. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol. 2010;63:681–686.

    Article  PubMed  Google Scholar 

  22. Parajuli R, Bjerkaas E, Tverdal A, Le Marchand L, Weiderpass E, Gram IT. Cigarette smoking and colorectal cancer mortality among 602,242 norwegian males and females. Clin Epidemiol. 2014;6:137–145.

    PubMed Central  PubMed  Google Scholar 

  23. Parajuli R, Bjerkaas E, Tverdal A, et al. The increased risk of colon cancer due to cigarette smoking may be greater in women than men. Cancer Epidemiol Biomarkers Prev. 2013;22:862–871.

    Article  PubMed  Google Scholar 

  24. Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology. 2008;134:388–395.

    Article  PubMed  Google Scholar 

  25. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. JAMA. 2008;300:2765–2778.

    Article  CAS  PubMed  Google Scholar 

  26. Giovannucci E, Colditz GA, Stampfer MJ, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst. 1994;86:192–199.

    Article  CAS  PubMed  Google Scholar 

  27. Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C, Calle EE. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst. 2000;92:1888–1896.

    Article  CAS  PubMed  Google Scholar 

  28. Zisman AL, Nickolov A, Brand RE, Gorchow A, Roy HK. Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening. Arch Intern Med. 2006;166:629–634.

    Article  PubMed  Google Scholar 

  29. Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst. 2000;92:1831–1836.

    Article  CAS  PubMed  Google Scholar 

  30. Limsui D, Vierkant RA, Tillmans LS, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010;102:1012–1022.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Samadder NJ, Vierkant RA, Tillmans LS, et al. Cigarette smoking and colorectal cancer risk by KRAS mutation status among older women. Am J Gastroenterol. 2012;107:782–789.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007;86:556–565.

    CAS  PubMed  Google Scholar 

  33. MacInnis RJ, English DR, Hopper JL, Gertig DM, Haydon AM, Giles GG. Body size and composition and colon cancer risk in women. Int J Cancer. 2006;118:1496–1500.

    Article  CAS  PubMed  Google Scholar 

  34. Keimling M, Renehan AG, Behrens G, et al. Comparison of associations of body mass index, abdominal adiposity, and risk of colorectal cancer in a large prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2013;22:1383–1394.

    Article  PubMed  Google Scholar 

  35. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–578.

    Article  PubMed  Google Scholar 

  36. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the european prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst. 2006;98:920–931.

    Article  PubMed  Google Scholar 

  37. Okabayashi K, Ashrafian H, Hasegawa H, et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol.. 2012;107:1175–1185. quiz 1186.

    Article  PubMed  Google Scholar 

  38. Kitahara CM, Berndt SI, de Gonzalez AB, et al. Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol. 2013;31:2450–2459.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Kabat GC, Anderson ML, Heo M, et al. Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2013;22:1353–1363.

    Article  CAS  PubMed  Google Scholar 

  40. Giovannucci E, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk of colorectal adenoma in women (united states). Cancer Causes Control. 1996;7:253–263.

    Article  CAS  PubMed  Google Scholar 

  41. Martinez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA. Leisure-time physical activity, body size, and colon cancer in women. Nurses’ health study research group. J Natl Cancer Inst. 1997;89:948–955.

    Article  CAS  PubMed  Google Scholar 

  42. Jacobs ET, Thompson PA, Martinez ME. Diet, gender, and colorectal neoplasia. J Clin Gastroenterol. 2007;41:731–746.

    Article  PubMed  Google Scholar 

  43. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med. 1990;323:1664–1672.

    Article  CAS  PubMed  Google Scholar 

  44. Chao A, Thun MJ, Connell CJ, et al. Meat consumption and risk of colorectal cancer. JAMA. 2005;293:172–182.

    Article  CAS  PubMed  Google Scholar 

  45. Ferrucci LM, Sinha R, Graubard BI, et al. Dietary meat intake in relation to colorectal adenoma in asymptomatic women. Am J Gastroenterol. 2009;104:1231–1240.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  46. Fung TT, Hu FB, Schulze M, et al. A dietary pattern that is associated with C-peptide and risk of colorectal cancer in women. Cancer Causes Control. 2012;23:959–965.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Bao Y, Nimptsch K, Chan AT, et al. Reported behavior of eating anything at anytime and risk of colorectal cancer in women. Int J Cancer. 2012;130:1395–1400.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. Makambi KH, Agurs-Collins T, Bright-Gbebry M, Rosenberg L, Palmer JR, Adams-Campbell LL. Dietary patterns and the risk of colorectal adenomas: the black women’s health study. Cancer Epidemiol Biomarkers Prev. 2011;20:818–825.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Michels KB, Giovannucci E, Chan AT, Singhania R, Fuchs CS, Willett WC. Fruit and vegetable consumption and colorectal adenomas in the nurses’ health study. Cancer Res. 2006;66:3942–3953.

    Article  CAS  PubMed  Google Scholar 

  50. Beresford SA, Johnson KC, Ritenbaugh C, et al. Low-fat dietary pattern and risk of colorectal cancer: the women’s health initiative randomized controlled dietary modification trial. JAMA. 2006;295:643–654.

    Article  CAS  PubMed  Google Scholar 

  51. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97:1679–1687.

    Article  PubMed  Google Scholar 

  52. Limburg PJ, Anderson KE, Johnson TW, et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa women’s health study. Cancer Epidemiol Biomarkers Prev. 2005;14:133–137.

    PubMed  Google Scholar 

  53. Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999;91:542–547.

    Article  CAS  PubMed  Google Scholar 

  54. Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol. 2011;106:1911–1921.

    Article  PubMed Central  PubMed  Google Scholar 

  55. Elwing JE, Gao F, Davidson NO, Early DS. Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women. Am J Gastroenterol. 2006;101:1866–1871.

    Article  PubMed  Google Scholar 

  56. Dash C, Palmer JR, Boggs DA, Rosenberg L, Adams-Campbell LL. Type 2 diabetes and the risk of colorectal adenomas: black women’s health study. Am J Epidemiol. 2014;179:112–119.

    Article  PubMed Central  PubMed  Google Scholar 

  57. McGregor SE, Hilsden RJ, Li FX, Bryant HE, Murray A. Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening. Am J Gastroenterol. 2007;102:1727–1735.

    Article  PubMed  Google Scholar 

  58. U.S. Preventive Services Task Force. Services Task Force. Screening for colorectal cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2008;149:627–637.

    Article  Google Scholar 

  59. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the united states. Cancer Epidemiol Biomarkers Prev. 2006;15:389–394.

    Article  PubMed  Google Scholar 

  60. Lieberman DA, Williams JL, Holub JL, et al. Colonoscopy utilization and outcomes 2000 to 2011. Gastrointest Endosc. 2014;80:133–143.

    Article  PubMed  Google Scholar 

  61. Segnan N, Senore C, Andreoni B, et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology. 2007;132:2304–2312.

    Article  PubMed  Google Scholar 

  62. Salas D, Vanaclocha M, Ibanez J, et al. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening. Cancer Causes Control. 2014;25:985–997.

    Article  PubMed  Google Scholar 

  63. Etzioni DA, Ponce NA, Babey SH, et al. A population-based study of colorectal cancer test use: results from the 2001 california health interview survey. Cancer. 2004;101:2523–2532.

    Article  PubMed  Google Scholar 

  64. Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152:668–676.

    Article  PubMed  Google Scholar 

  65. Farraye FA, Wong M, Hurwitz S, et al. Barriers to endoscopic colorectal cancer screening: are women different from men? Am J Gastroenterol. 2004;99:341–349.

    Article  PubMed  Google Scholar 

  66. Schneider A, Kanagarajan N, Anjelly D, Reynolds JC, Ahmad A. Importance of gender, socioeconomic status, and history of abuse on patient preference for endoscopist. Am J Gastroenterol.. 2009;104:340–348.

    Article  PubMed  Google Scholar 

  67. Wardle J, Miles A, Atkin W. Gender differences in utilization of colorectal cancer screening. J Med Screen. 2005;12:20–27.

    Article  CAS  PubMed  Google Scholar 

  68. Menees SB, Inadomi JM, Korsnes S, Elta GH. Women patients’ preference for women physicians is a barrier to colon cancer screening. Gastrointest Endosc. 2005;62:219–223.

    Article  PubMed  Google Scholar 

  69. Stockwell DH, Woo P, Jacobson BC, et al. Determinants of colorectal cancer screening in women undergoing mammography. Am J Gastroenterol. 2003;98:1875–1880.

    Article  PubMed  Google Scholar 

  70. Denberg TD, Kraus H, Soenksen A, Mizrahi T, Shields L, Lin CT. Rates of screening colonoscopy are not increased when women are offered a female endoscopist in a health promotion outreach program. Gastrointest Endosc. 2010;72:1014–1019.

    Article  PubMed  Google Scholar 

  71. Rosen AB, Schneider EC. Colorectal cancer screening disparities related to obesity and gender. J Gen Intern Med. 2004;19:332–338.

    Article  PubMed Central  PubMed  Google Scholar 

  72. Heo M, Allison DB, Fontaine KR. Overweight, obesity, and colorectal cancer screening: disparity between men and women. BMC Public Health. 2004;4:53.

    Article  PubMed Central  PubMed  Google Scholar 

  73. Chao A, Connell CJ, Cokkinides V, Jacobs EJ, Calle EE, Thun MJ. Underuse of screening sigmoidoscopy and colonoscopy in a large cohort of US adults. Am J Public Health. 2004;94:1775–1781.

    Article  PubMed Central  PubMed  Google Scholar 

  74. Leone LA, Campbell MK, Satia JA, Bowling JM, Pignone MP. Race moderates the relationship between obesity and colorectal cancer screening in women. Cancer Causes Control. 2010;21:373–385.

    Article  PubMed Central  PubMed  Google Scholar 

  75. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575–582.

    Article  PubMed Central  PubMed  Google Scholar 

  76. Cram P, Fendrick AM, Inadomi J, Cowen ME, Carpenter D, Vijan S. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med. 2003;163:1601–1605.

    Article  PubMed  Google Scholar 

  77. Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106–1114.

    Article  CAS  PubMed  Google Scholar 

  78. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345–2357.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  79. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the italian randomized controlled trial—SCORE. J Natl Cancer Inst. 2011;103:1310–1322.

    Article  PubMed  Google Scholar 

  80. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624–1633.

    Article  PubMed  Google Scholar 

  81. Imperiale TF, Glowinski EA, Lin-Cooper C, Ransohoff DF. Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia. Am J Med. 2012;125:1181–1187.

    Article  PubMed Central  PubMed  Google Scholar 

  82. Schoenfeld P, Cash B, Flood A, et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med. 2005;352:2061–2068.

    Article  CAS  PubMed  Google Scholar 

  83. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. veterans affairs cooperative study group 380. N Engl J Med. 2000;343:162–168.

    Article  CAS  PubMed  Google Scholar 

  84. Ramakrishnan K, Scheid DC. Predictors of incomplete flexible sigmoidoscopy. J Am Board Fam Pract. 2003;16:478–484.

    Article  PubMed  Google Scholar 

  85. Eloubeidi MA, Wallace MB, Desmond R, Farraye FA. Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer. Am J Gastroenterol. 2003;98:1634–1639.

    Article  PubMed  Google Scholar 

  86. Farraye FA, Horton K, Hersey H, Trnka Y, Heeren T, Provenzale D. Screening flexible sigmoidoscopy using an upper endoscope is better tolerated by women. Am J Gastroenterol. 2004;99:1074–1080.

    Article  PubMed  Google Scholar 

  87. Lakoff J, Paszat LF, Saskin R, Rabeneck L. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol. 2008;6:1117–1121. quiz 1064.

    Article  PubMed  Google Scholar 

  88. Singh H, Turner D, Xue L, Targownik LE, Bernstein CN. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA. 2006;295:2366–2373.

    Article  CAS  PubMed  Google Scholar 

  89. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369:1095–1105.

    Article  CAS  PubMed  Google Scholar 

  90. Brenner H, Chang-Claude J, Seiler CM, Hoffmeister M. Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol.. 2011;29:3761–3767.

    Article  PubMed  Google Scholar 

  91. Brenner H, Chang-Claude J, Seiler CM, Hoffmeister M. Interval cancers after negative colonoscopy: population-based case-control study. Gut. 2012;61:1576–1582.

    Article  PubMed  Google Scholar 

  92. Singh H, Nugent Z, Mahmud SM, Demers AA, Bernstein CN. Predictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol. 2010;105:663–673. quiz 674.

    Article  PubMed  Google Scholar 

  93. Singh H, Nugent Z, Demers AA, Bernstein CN. Rate and predictors of early/missed colorectal cancers after colonoscopy in manitoba: a population-based study. Am J Gastroenterol.. 2010;105:2588–2596.

    Article  PubMed  Google Scholar 

  94. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology. 2007;132:96–102.

    Article  PubMed  Google Scholar 

  95. Anderson JC, Messina CR, Cohn W, et al. Factors predictive of difficult colonoscopy. Gastrointest Endosc. 2001;54:558–562.

    Article  CAS  PubMed  Google Scholar 

  96. Shah HA, Paszat LF, Saskin R, Stukel TA, Rabeneck L. Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology. 2007;132:2297–2303.

    Article  PubMed  Google Scholar 

  97. Dafnis G, Granath F, Pahlman L, Ekbom A, Blomqvist P. Patient factors influencing the completion rate in colonoscopy. Dig Liver Dis. 2005;37:113–118.

    Article  CAS  PubMed  Google Scholar 

  98. Garrett KA, Church J. History of hysterectomy: a significant problem for colonoscopists that is not present in patients who have had sigmoid colectomy. Dis Colon Rectum. 2010;53:1055–1060.

    Article  PubMed  Google Scholar 

  99. Shah SG, Brooker JC, Thapar C, Williams CB, Saunders BP. Patient pain during colonoscopy: an analysis using real-time magnetic endoscope imaging. Endoscopy. 2002;34:435–440.

    Article  CAS  PubMed  Google Scholar 

  100. Marshall JB, Perez RA, Madsen RW. Usefulness of a pediatric colonoscope for routine colonoscopy in women who have undergone hysterectomy. Gastrointest Endosc. 2002;55:838–841.

    Article  PubMed  Google Scholar 

  101. Saunders BP, Fukumoto M, Halligan S, et al. Why is colonoscopy more difficult in women? Gastrointest Endosc. 1996;43:124–126.

    Article  CAS  PubMed  Google Scholar 

  102. Rowland RS, Bell GD, Dogramadzi S, Allen C. Colonoscopy aided by magnetic 3D imaging: is the technique sufficiently sensitive to detect differences between men and women? Med Biol Eng Comput. 1999;37:673–679.

    Article  CAS  PubMed  Google Scholar 

  103. Khashab MA, Pickhardt PJ, Kim DH, Rex DK. Colorectal anatomy in adults at computed tomography colonography: normal distribution and the effect of age, sex, and body mass index. Endoscopy. 2009;41:674–678.

    Article  CAS  PubMed  Google Scholar 

  104. Lebwohl B, Capiak K, Neugut AI, Kastrinos F. Risk of colorectal adenomas and advanced neoplasia in hispanic, black and white patients undergoing screening colonoscopy. Aliment Pharmacol Ther. 2012;35:1467–1473.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  105. Carethers JM, Murali B, Yang B, et al. Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer. PLoS One. 2014;9:e100461.

    Article  PubMed Central  PubMed  Google Scholar 

  106. Murphy G, Devesa SS, Cross AJ, Inskip PD, McGlynn KA, Cook MB. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer. 2011;128:1668–1675.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  107. Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet.. 2010;376:1741–1750.

    Article  CAS  PubMed  Google Scholar 

  108. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377:31–41.

    Article  CAS  PubMed  Google Scholar 

  109. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995;333:609–614.

    Article  CAS  PubMed  Google Scholar 

  110. Cook NR, Lee IM, Zhang SM, Moorthy MV, Buring JE. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med. 2013;159:77–85.

    Article  PubMed Central  PubMed  Google Scholar 

  111. Mahipal A, Anderson KE, Limburg PJ, Folsom AR. Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the iowa women’s health study. Cancer Epidemiol Biomarkers Prev. 2006;15:1785–1790.

    Article  CAS  PubMed  Google Scholar 

  112. Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst. 2009;101:256–266.

    Article  CAS  PubMed  Google Scholar 

  113. Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the nurses’ health study. Ann Intern Med. 1998;129:517–524.

    Article  CAS  PubMed  Google Scholar 

  114. Terry P, Jain M, Miller AB, Howe GR, Rohan TE. Dietary intake of folic acid and colorectal cancer risk in a cohort of women. Int J Cancer. 2002;97:864–867.

    Article  CAS  PubMed  Google Scholar 

  115. Zhang SM, Moore SC, Lin J, et al. Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol. 2006;163:108–115.

    Article  PubMed Central  PubMed  Google Scholar 

  116. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297:2351–2359.

    Article  CAS  PubMed  Google Scholar 

  117. Mursu J, Robien K, Harnack LJ, Park K, Jacobs DR Jr. Dietary supplements and mortality rate in older women: the iowa women’s health study. Arch Intern Med. 2011;171:1625–1633.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  118. Alberts DS, Ritenbaugh C, Story JA, et al. Randomized, double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous colon polyps. J Natl Cancer Inst. 1996;88:81–92.

    Article  CAS  PubMed  Google Scholar 

  119. Lampe JW, Slavin JL, Melcher EA, Potter JD. Effects of cereal and vegetable fiber feeding on potential risk factors for colon cancer. Cancer Epidemiol Biomarkers Prev. 1992;1:207–211.

    CAS  PubMed  Google Scholar 

  120. Fuchs CS, Giovannucci EL, Colditz GA, et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med. 1999;340:169–176.

    Article  CAS  PubMed  Google Scholar 

  121. Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. polyp prevention trial study group. N Engl J Med. 2000;342:1149–1155.

    Article  CAS  PubMed  Google Scholar 

  122. McKeown-Eyssen GE, Bright-See E, Bruce WR, et al. A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps. Toronto polyp prevention group. J Clin Epidemiol. 1994;47:525–536.

    Article  CAS  PubMed  Google Scholar 

  123. MacLennan R, Macrae F, Bain C, et al. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. J Natl Cancer Inst. 1995;87:1760–1766.

    Article  CAS  PubMed  Google Scholar 

  124. Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. phoenix colon cancer prevention physicians’ network. N Engl J Med. 2000;342:1156–1162.

    Article  CAS  PubMed  Google Scholar 

  125. Bostick RM, Potter JD, McKenzie DR, et al. Reduced risk of colon cancer with high intake of vitamin E: the iowa women’s health study. Cancer Res. 1993;53:4230–4237.

    CAS  PubMed  Google Scholar 

  126. Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp prevention study group. N Engl J Med. 1994;331:141–147.

    Article  CAS  PubMed  Google Scholar 

  127. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the women’s health study: A randomized controlled trial. JAMA. 2005;294:56–65.

    Article  CAS  PubMed  Google Scholar 

  128. Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37–46.

    Article  CAS  PubMed  Google Scholar 

  129. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361:2017–2023.

    Article  CAS  PubMed  Google Scholar 

  130. Martinez ME, Giovannucci EL, Colditz GA, et al. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst. 1996;88:1375–1382.

    Article  CAS  PubMed  Google Scholar 

  131. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684–696.

    Article  CAS  PubMed  Google Scholar 

  132. Lin J, Zhang SM, Cook NR, Manson JE, Lee IM, Buring JE. Intakes of calcium and vitamin D and risk of colorectal cancer in women. Am J Epidemiol. 2005;161:755–764.

    Article  PubMed  Google Scholar 

  133. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. calcium polyp prevention study group. N Engl J Med. 1999;340:101–107.

    Article  CAS  PubMed  Google Scholar 

  134. Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ. 2008;336:262–266.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  135. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  136. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994;7:536–540.

    Article  CAS  PubMed  Google Scholar 

  137. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW. Selective loss of estrogen receptor beta in malignant human colon. Cancer Res. 2000;60:245–248.

    CAS  PubMed  Google Scholar 

  138. Campagnoli C, Biglia N, Altare F, et al. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol. 1993;7:251–258.

    Article  CAS  PubMed  Google Scholar 

  139. Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res. 2008;68:329–337.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  140. Everson GT, McKinley C, Kern F Jr. Mechanisms of gallstone formation in women. effects of exogenous estrogen (premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest. 1991;87:237–246.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  141. McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst. 1980;65:1201–1207.

    CAS  PubMed  Google Scholar 

  142. Grodstein F, Martinez ME, Platz EA, et al. Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med. 1998;128:705–712.

    Article  CAS  PubMed  Google Scholar 

  143. Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women’s health initiative randomized trials. JAMA. 2013;310:1353–1368.

    Article  CAS  PubMed  Google Scholar 

  144. Simon MS, Chlebowski RT, Wactawski-Wende J, et al. Estrogen plus progestin and colorectal cancer incidence and mortality. J Clin Oncol. 2012;30:3983–3990.

    Article  PubMed Central  PubMed  Google Scholar 

  145. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004;350:991–1004.

    Article  CAS  PubMed  Google Scholar 

  146. Hulley S, Furberg C, Barrett-Connor E, et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). JAMA. 2002;288:58–66.

    Article  CAS  PubMed  Google Scholar 

  147. Pence BC, Belasco EJ, Lyford CP. Combination aspirin and/or calcium chemoprevention with colonoscopy in colorectal cancer prevention: cost-effectiveness analyses. Cancer Epidemiol Biomarkers Prev. 2013;22:399–405.

    Article  PubMed  Google Scholar 

  148. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 11 (internet). Lyon: International Agency for Research on Cancer; 2013. Available from http://globocan.iarc.fr. Accessed 24 Nov 2014.

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Gastroenterology and Hepatology, Denver Veterans Affairs Medical Center, Denver, CO, USA

    Lyssa Chacko

  2. Department of Gastroenterology and Hepatology, Cleveland Clinic, Desk A 30, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Carole Macaron & Carol A. Burke

Authors
  1. Lyssa Chacko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carole Macaron
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carol A. Burke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carol A. Burke.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chacko, L., Macaron, C. & Burke, C.A. Colorectal Cancer Screening and Prevention in Women. Dig Dis Sci 60, 698–710 (2015). https://doi.org/10.1007/s10620-014-3452-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-014-3452-4

Keywords

Search

Navigation